Great Lakes

Resilience System


You are here

Data

States Expand Vaccine Eligibility Amid a Stubborn U.S. Caseload

Covid-19 Live News: States Expand Vaccine Eligibility Amid a Stubborn U.S. Caseload

New York Times

States are racing to vaccinate as many people as possible as the United States’ coronavirus infection curve continues its plateau for a third week at more than 55,000 new cases per day, a level that health experts warn could rapidly escalate into a new wave.

That prospect adds further urgency to vaccination efforts, even as some states appear confident that their inoculation levels justify loosening restrictions.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

New statement: AstraZeneca COVID-19 vaccine 76% effective in updated U.S. trial results

After results are questioned, AstraZeneca says complete data shows its vaccine is still highly effective.

https://www.nytimes.com/live/2021/03/24/world/covid-vaccine-coronavirus-cases#after-results-are-questioned-astrazeneca-says-complete-data-shows-its-vaccine-is-still-highly-effective

AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the disease, based on more recent data than was included when the company announced the interim results of its U.S. clinical trial on Monday.

The company said in a news release that its vaccine was 76 percent effective at preventing Covid-19. That is slightly lower than the efficacy number that the company announced earlier this week.

Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Data
howdy folks
Page loaded in 0.664 seconds.